TY  - JOUR
AU  - Rial Crestelo, David
AU  - Rubio García, Rafael
AU  - Delgado Vázquez, Rafael
AU  - Pulido Ortega, Federico
AU  - Arribas JR
PY  - 2021
DO  - 10.1093/jac/dkaa479
UR  - https://hdl.handle.net/20.500.14352/105343
T2  - Journal of Antimicrobial Chemotherapy
AB  - Background: In the ART-PRO pilot trial there were no virological failures through 48 weeks of treatment with dolutegravir plus lamivudine in suppressed individuals with and without archived lamivudine resistance-associated mutations (RAMs) detected...
LA  - eng
M2  - 738
KW  - Dolutegravir
KW  - Lamivudine
KW  - HIV
KW  - HIV viral suppression
TI  - Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
TY  - journal article
VL  - 76
ER  -